Applicant, as named in the Orange Book

Adamis Pharms Corp

Next listed expiry: Symjepi on 20 Oct 2036. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Symjepi epinephrine	epinephrine	207534	20 Oct 2036	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.